Back
Oculis Holding AG 10K Form
Sell
17
OCS
Oculis Holding AG
Last Price:
$27.69
Seasonality Move:
-4.37%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive OCS News And Ratings
See the #1 stock for the next 7 days that we like better than OCS
OCS Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-18M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $3.13 |
| Price / Book: | 9.76 |
Profitability
| EPS (TTM): | -2.28020 |
|---|---|
| Net Income (TTM): | $-118.1M |
| Gross Margin: | $-461K |
| Return on Equity: | -68.98% |
| Return on Assets: | -53.67% |
Oculis Holding AG Earnings Forecast
Key Oculis Holding AG Financial Ratios
-
Per Share Earnings over the last 5 years have been positive in 2 years.
Oculis Holding AG Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | OCS |
| Website: | oculis.com |
Debt
| Debt-to-Equity Ratio: | 0.01 |
|---|---|
| Current Ratio: | 5.96 |
| Quick Ratio: | 5.8 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 119.97 |
OCS Technical Analysis vs Fundamental Analysis
Sell
17
Oculis Holding AG (OCS)
is a Sell
Is Oculis Holding AG a Buy or a Sell?
-
Oculis Holding AG stock is rated a SellThe current Oculis Holding AG [OCS] share price is $27.72. The Score for OCS is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.